Journey to Policy: Unpacking Wins in Successful O&P Advocacy 

Date and Time

August 29, 2024
12–1 p.m. CT

Location

Virtual Event

Cost: Free
CE Contact Hours: 60 minutes

CE Credit is pending for the American Board of Certification in Orthotics, Prosthetics & Pedorthics; Commission for Case Manager Certification; American Occupational Therapy Association; and various Physical Therapy State Boards.


About This Course

Medicare recently released its revised coverage criteria for microprocessor knees (MPKs) and added clarifying language to its definitions of K-levels through a revised Prosthetic Local Coverage Determination (LCD) and Policy Article.

These changes represent a positive advancement for patients resulting from a collaborative, industry-wide effort focused on collected outcomes and published clinical studies. In this session, researchers, advocacy leaders, and patients will provide insights on effective advocacy strategies, the importance of building a robust body of evidence, and the value of a patient-centered collaborative approach to ensuring proposed policies are enacted. Join us as we discuss the evolving landscape of advocacy and how we can work together to drive meaningful legislative and regulatory outcomes for patients with limb loss everywhere.

Register Now


Objectives

Upon completion of this program, participants should be able to: 

  1. Explore the critical role that a strategic advocacy approach plays in achieving policy changes within the healthcare system, particularly for orthotic and prosthetic (O&P) patients.
  2. Explain the importance of building a strong body of evidence and how that contributes to policy reform and success, as well as where to go to find supportive evidence for a given policy change.
  3. Assess how advancements in technology, such as microprocessor-controlled knees, influence patient care and the necessity for patient-centered approaches in advocacy efforts to effectively shape legislative and regulatory outcomes.
  4. Describe current evidence that is helping to shape care for relevant patient populations.

Session Outline + Timed Agenda

  • Introduction: 5 min 
  • Panel Discussion: 40 min 
    • Global Advocacy Efforts and a Collaborative Approach 
    • Body of Evidence 
    • Patient Impact and Outcomes 
  • Questions & Answers: 15 min 

Speakers